Drug Discovery & Development |
Diabetes Drug Gains Approval for Treatment of Obesity
New York Times The Food and Drug Administration approved a Novo Nordisk diabetes drug as a treatment for obesity, the first injectable drug approved for weight loss. The drug, liraglutide, will be marketed under the brand name Saxenda for obese adults and for … FDA approves weight-management drug SaxendaFDA.gov FDA approves Novo Nordisk's injection for obesityCNBC Novo Nordisk kick-starts its obesity franchise with a long-awaited FDA nodFierceBiotech CBS News –Skin and Allergy News Digital Network –Minneapolis Star Tribune all 118 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.